EUVIMEDEUVIMED entdecken
Crossref

Immunotherapy and the evolving trajectory of type 1 diabetes: management to prevention

Aysha Mendes

Journal of Prescribing Practice · 02.07.2026 · 8 (7) · 274-276

DOI: 10.12968/jprp.2026.0075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Prescribing Practice, erschienen am 02.07.2026. Verfasst von Aysha Mendes. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aysha Mendes explores the evidence behind teplizumab, reviews the wider immunotherapy landscape in T1D and considers the implications of this evolving field for prescribing practice

Zitieren

APA

Mendes, A. (2026). Immunotherapy and the evolving trajectory of type 1 diabetes: management to prevention. Journal of Prescribing Practice, 8(7), 274-276. https://doi.org/10.12968/jprp.2026.0075

Vancouver

Mendes A. Immunotherapy and the evolving trajectory of type 1 diabetes: management to prevention. Journal of Prescribing Practice. 2026;8(7):274-276. doi:10.12968/jprp.2026.0075

BibTeX
@article{Mendes2026,
  author = {Mendes, Aysha},
  title = {Immunotherapy and the evolving trajectory of type 1 diabetes: management to prevention},
  journal = {Journal of Prescribing Practice},
  year = {2026},
  volume = {8},
  number = {7},
  pages = {274--276},
  doi = {10.12968/jprp.2026.0075}
}
Kostenlos starten →